
19 May 2025 - 23 May 2025
Seminar
We are pleased to invite you to join an exclusive Healthcare Venture Capital Delegation to Norway from May 19-23, facilitated by Innovation Norway New York.
Join us for an exclusive investor programme in Norway, combining high-level networking, premier industry events, and tailored company introductions. Discover investment opportunities in Nordic biopharma, medtech, and healthtech while connecting with key stakeholders in Oslo and Bergen.
May 19 – Arrival in Oslo
May 20-21 – Bergen | LSX Nordic Congress
May 22-23 – Oslo | Investor, Start-up & Government Meetings
This delegation offers a unique opportunity to explore Norway’s thriving life sciences and technology ecosystem, connect with top Nordic startups, and engage with local investors, government funds, and key industry players.
This trip is an excellent opportunity to identify promising investment targets, build strategic relationships, and gain firsthand insight into one of Europe’s most dynamic innovation ecosystems.
Exclusive insights into Norway’s funding landscape, key growth sectors, and emerging opportunities.Please confirm your interest by April 29th to secure your spot. For any questions, feel free to reach out.
We look forward to welcoming you to Norway!
Participants are responsible for covering transportation and accommodation
We generate visibility for Norwegian companies, making it easier for international companies to find the solutions, services and partners they are looking for.
All times are in GMT
09:00 - 18:00
09:00 - 18:00
Evening: Exclusive investor networking dinner
All times are in GMT
09:00 - 18:00
09:00 - 18:00
Participate in LSX Nordic Congress (LSX Nordic Congress), a premier gathering of investors, biopharma, medtech and healthtech leaders, and growth-stage companies. • High-level networking with Nordic entrepreneurs and fellow local and international investors. • Qualified investors attend free of charge if signed up before April 29th: https://informaconnect.com/lsx-nordic-congress/investor/
All times are in GMT
09:00 - 18:00
09:00 - 18:00
Engage with local venture capital funds, government-backed investors, and Innovation Norway. • Tailored company introductions based on investment interests. • Exclusive insights into Norway’s funding landscape, key growth sectors, and emerging opportunities.
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.
